Taking the Long View: LA ART for HIV Treatment and Prevention

Learn with the experts about the latest data and developments on the current and future roles of long-acting ART in HIV treatment and prevention strategies. Listen to podcasts read ClinicalThought faculty commentaries download slidesets and patient education sheets or watch the on-demand multimedia module of this engaging symposium.

Share

Program Content

Activities

Current LA ART and PrEP
Current Landscape of Long-Acting ART for Treatment and Prevention of HIV
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 14, 2022

Expires: June 13, 2023

Incorporating LA ART
Incorporating Long-Acting ART for Treatment and Prevention Into Clinical Practice
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 14, 2022

Expires: June 13, 2023

Potential Future LA ART
Emerging Long-Acting ART Regimens for HIV Treatment and Prevention
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 14, 2022

Expires: June 13, 2023

Activities

LA ART: Candidacy and Counseling
Switching to Long-Acting Cabotegravir Plus Rilpirivine for HIV Treatment: Assessing Candidacy and Patient Counseling
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: July 14, 2022

Expires: July 13, 2023

LA ART: System Considerations
Implementing Long-Acting Cabotegravir Plus Rilpivirine for HIV Treatment: System-Level Considerations
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: August 02, 2022

Expires: August 01, 2023

LA PrEP
Long-Acting Cabotegravir for HIV Prevention
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: September 09, 2022

Expires: September 08, 2023

Future LA HIV Care
The Future of Long-Acting HIV Care: What’s Still Needed
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: December 22, 2022

Expires: December 21, 2023

Activities

LA ART: Patient Selection
Injectable Long-Acting ART: Optimizing Evidence-Based Candidate Selection
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 25, 2022

Expires: July 24, 2023

LA ART: Mode of Use
Injectable Long-Acting CAB + RPV: Choices for Mode of Use
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 12, 2022

Expires: August 11, 2023

LA PrEP: Community Delivery
Long-Acting HIV PrEP Is Here: What Will Be Needed to Move It Into Community-Based Settings
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: September 12, 2022

Expires: September 11, 2023

LA ART and PrEP: Women
Long-Acting Injectable HIV Treatment and Prevention: Key Considerations for Women
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: October 13, 2022

Expires: October 12, 2023

LA HIV Care: Fear of Change
Overcoming Fear of Change to Fulfill the Promise of Long-Acting HIV Care
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: November 16, 2022

Expires: November 15, 2023

Lenacapavir
What’s Next in LA ART: Lenacapavir
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: December 19, 2022

Expires: December 18, 2023

Activities

Video: LA HIV Treatment
Taking the Long View: LA ART for HIV Treatment and Prevention
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: July 29, 2022

Expires: July 28, 2023

Activities

Patient Education: LA ART
Patient Education PDF on Long-Acting HIV Care: The Long and Short of Long-Acting ART
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: October 28, 2022

Expires: October 27, 2023

Patient Education: LA PrEP
Patient Education on Long-Acting HIV Care: HIV PrEP
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: December 19, 2022

Expires: December 18, 2023

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

ViiV Healthcare